KL1333

NeuroVive's KL1333 Receives FDA Orphan Drug Designation for Treatment of Mitochondrial Diseases
CP Wire
Wed, 04/18/18 - 07:21 pm
NeuroVive
KL1333
MRCD
orphan drug